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malities of the mitral valve apparatus. Second, in such patients
aggressive treatment with vasodilators should be avoided because
they may precipitate or worsen the dynamic obstruction. In
contrast, beta-blockers should blunt the hyperdynamic contraction
and thus, in addition to the reduction of arrhythmias and work
load, prevent the fatal cardiac rupture (4). We believe that
discussion of these mechanisms could stimulate other investigators
to look carefully at LVOT dynamics in patients with anterior
myocardial infarction to determine whether compensatory hyper-
dynamic contractions of the basis of the heart may indeed be
deleterious in these patients.
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REPLY
The work of Bartunek et al. (1) is well known and respected in the
field of echocardiography, and their elegant work concerning the
mechanism of outflow tract obstruction after aortic valve replace-
ment for aortic stenosis represents the definitive study on this
subject. We are greatly interested in their more recent work
concerning cardiac rupture in two elderly women with anterior
myocardial infarction, dynamic outflow tract gradient and a doc-
umented ventricular septal defect in one patient and possible left
ventricular free wall rupture in the other.
Their hypothesis of increased wall stress, occasioned by dynamic
outflow obstruction due to hyperdynamic basal wall contraction as
a possible trigger to cardiac rupture, is novel and plausible. We
have recently observed an instance where outflow tract obstruction,
as demonstrated by transesophageal echocardiography, was the
cause for profound hypotension in a patient who had a large
anteroapical myocardial infarction.
The pressure theory of cardiac rupture is widely quoted (2) and,
in combination with a vulnerable myocardium, provides the re-
quired substrate for an often fatal event. Although our study did
not have premorbid echocardiographic information (3), data de-
rived from the Late Assessment of Thrombolytic Efficacy (LATE)
study (4), National Registry of Myocardial Infarction (5) and
Thrombolysis and Thrombin Inhibition in Myocardial Infarction
(TIMI-9) experience (3) support Bartunek et al.’s hypothesis in the
following ways. First, an anterior site of infarction was present in
.50% of patients. Second, although a previous myocardial infarc-
tion was an independent risk factor for cardiac death, it was not
common in patients with a fatal cardiac rupture. This observation
suggests that preservation of left ventricular performance in the
noninfarct zone is a prerequisite for rupture and is supported by the
relatively low proportion of patients with cardiac rupture initially
classified as Killip class III or higher (4). Lastly, the protective
effect of beta-blockers is consistent with an intracavity pressure
trigger for cardiac rupture. Despite the fact that angiotensin-
converting enzyme (ACE) inhibitors and other vasodilators could
potentially worsen a dynamic obstruction, similar to large-scale
trials (6), we observed an inverse relation between ACE inhibitor
use and the occurrence of cardiac rupture (odds ratio 0.27, p ,
0.0001). Clearly, several mechanisms contribute to cardiac rupture.
We agree with Bartunek et al. that future investigations carried
out among patients with myocardial infarction must include
studies of dynamic change in ventricular cavity performance as a
means to better understand the conditions required for cardiac
rupture and, more importantly, its prevention.
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